Abstract:Ethnopharmacological relevance Ginsenoside Rg1 (Rg1) is one of the main active components in Panax ginseng C. A. Meyer (ginseng), which has been widely used to delay senescence or improve health conditions for more than 2000 years. Increasing studies have revealed that Rg1 could regulate cell proliferation and differentiation, as well as anti-inflammatory and anti-apoptotic effects, and might have protective effects on many chronic kidney diseases. Aim of the study Diabetic nephropathy (DN) is one of the most dangerous microvascular complications of diabetes and is the leading cause of end-stage renal disease worldwide. However, the role and mechanism of Rg1 against high-glucose and high-fat-induced glomerular fibrosis in DN are not clear. This study aimed to investigate the protective effect of Rg1 on DN and its possible mechanism. Materials and methods The type 2 diabetes mellitus (T2DM) mice models were established with a high-fat diet (HFD) combined with an intraperitoneal injection of streptozotocin (STZ). Urine protein and serum biochemical indexes were detected by corresponding kits. The kidney was stained with H&E, PAS, and Masson to observe the pathological morphology, glycogen deposition, and fibrosis. The expression of CD36 and p-PLC in the kidney cortex was detected by IHC. The expressions of FN and COL4 were detected by IF. Western blot and PCR were performed to examine protein and mRNA expressions of kidney fibrosis and TRPC6/NFAT2-related pathways in DN mice. Calcium imaging was used to examine the effect of Rg1 on [Ca 2+ ] i in PA + HG-induced human mesangial cells (HMCs). Visualization of the interaction between Rg1 and CD36 was detected by molecular docking. Results Rg1 treatment for 8 weeks could prominently decrease urinary protein, serum creatinine, and urea nitrogen and downgrade blood lipid levels and renal lipid accumulation in T2DM mice. The pathological results indicated that Rg1 treatment attenuated renal pathological injury and glomerular fibrosis. The further results demonstrated that Rg1 treatment remarkably decreased the expressions of CD36, TRPC6, p-PLC, CN, NFAT2, TGF-β, p-Smad2/3, COL4, and FN in renal tissues from T2DM mice. Calcium imaging results found that Rg1 downgraded the base levels of [Ca 2+ ] i and ΔRatioF340/F380 after BAPTA and CaCl 2 treatment. Molecular docking results showed that Rg1 could interact with CD36 with a good affinity. Conclusion These results revealed that Rg1 could ameliorate renal lipid accumulation, pathological damage, and glomerular fibrosis in T2DM mice. The mechanism may be involved in reducing the overexpression of CD36 and inhibiting the TRPC6/NFAT2 signaling pathway in renal tissues of T2DM mice.

PC-1 NF Suppresses High Glucose-Stimulated Inflammation and Extracellular Matrix Accumulation in Glomerular Mesangial Cells Via the Wnt/β-catenin Signaling.

High Glucose-induced Fibronectin Upregulation in Cultured Mesangial Cells Involves Caveolin-1-dependent RhoA-GTP Activation Via Src Kinase

FOXP1 Inhibits High Glucose-Induced ECM Accumulation and Oxidative Stress in Mesangial Cells.

Effects of Polycystin‑1 N‑terminal Fragment Fusion Protein on the Proliferation and Apoptosis of Rat Mesangial Cells.

Effect of N-terminal Fragment Fusion Protein of Polycystin-1 on Apoptosis of Rat Mesangial Cells

CKIP-1 Ameliorates High Glucose-Induced Expression of Fibronectin and Intercellular Cell Adhesion Molecule-1 by Activating the Nrf2/ARE Pathway in Glomerular Mesangial Cells

High-Mobility Group Nucleosome-Binding Protein 1 Mediates Renal Fibrosis Correlating with Macrophages Accumulation and Epithelial-to-Mesenchymal Transition in Diabetic Nephropathy Mice Model.

Polydatin ameliorates experimental diabetes-induced fibronectin through inhibiting the activation of NF-κB signaling pathway in rat glomerular mesangial cells.

High Glucose/lysophosphatidylcholine Levels Stimulate Extracellular Matrix Deposition in Diabetic Nephropathy Via Platelet‑activating Factor Receptor.

Silencing CCNG1 protects MPC-5 cells from high glucose-induced proliferation-inhibition and apoptosis-promotion via MDM2/p53 signaling pathway

Ginsenoside Rg1 attenuates glomerular fibrosis by inhibiting CD36/TRPC6/NFAT2 signaling in type 2 diabetes mellitus mice

BML-111 Attenuates High Glucose-Induced Inflammation, Oxidative Stress and Reduces Extracellular Matrix Accumulation Via Targeting Nrf2 in Rat Glomerular Mesangial Cells

Role of HMGN1 in Epithelial-Mesenchymal Transition of Kidney Tubules in Diabetic Nephropathy Mice

Cytosolic Hmgb1 accumulation in mesangial cells aggravates diabetic kidney disease progression via NFκB signaling pathway

Sphingosine Kinase-1 Pathway Mediates High Glucose-Induced Fibronectin Expression in Glomerular Mesangial Cells.

Trigonelline reverses high glucose-induced proliferation, fibrosis of mesangial cells via modulation of Wnt signaling pathway

Progestin and AdipoQ Receptor 3 Upregulates Fibronectin and Intercellular Adhesion Molecule-1 in Glomerular Mesangial Cells Via Activating NF-κB Signaling Pathway under High Glucose Conditions

Involvement of Histone Lysine Methylation in P21 Gene Expression in Rat Kidney in Vivo and Rat Mesangial Cells in Vitro under Diabetic Conditions

Effects of the S1P/S1PR1 Signaling Pathway on High Glucose-Induced NRK-52E Epithelial-Mesenchymal Transition Via Regulation of ROS/NLRP3

Increased Transient Receptor Potential Canonical Type 1 Improves Diabetic Nephropathy Via Inhibiting Nf-Kappa B Pathway

Knockdown of Lncrna PVT1 Alleviates High Glucose-Induced Proliferation and Fibrosis in Human Mesangial Cells by Mir-23B-3p/wt1 Axis